Brazil advances towards its HPV vaccination goal
Brazil is close to reaching the 90% HPV vaccination target. This achievement reflects a sustained effort ...
Galicia launches a genetic project to treat breast cancer
The Xunta de Galicia has gathered 1,000 volunteers to participate in the pilot phase of the Xenoma Galicia project. This ...
More than 800 million euros for research in Spain
The Ministry of Science, Innovation and Universities (MICIU), through the State Research Agency (AEI), has published the ...
Listeriosis and other zoonotic diseases on the rise: how it is spread and how to prevent it
The panorama of zoonotic diseases in the European Union (EU) remains worrying, as reflected in the annual report ...
EBRD invests €10 million in JGL to boost sustainability and reduce emissions
The European Bank for Reconstruction and Development (EBRD) continues to support sustainability and emissions reduction in Croatia. The ...
Physical exercise as a cause of Anaphylaxis
Anaphylaxis is a severe and rapid reaction that can be fatal. Learn about its causes, symptoms, risk factors and treatment options.
WHO prequalifies a diagnostic test for tuberculosis for the first time
In an announcement that marks a milestone in the fight against one of the world's deadliest infectious diseases, ...
FDA approves Imfinzi as first treatment for small cell lung cancer
The U.S. Food and Drug Administration (FDA) has approved AstraZeneca's Imfinzi (durvalumab). It is the first treatment for ...
Tiziana expands trial of foralumab to treat multiple sclerosis SPMS
Tiziana Life Sciences, a biotechnology company developing innovative immunomodulatory therapies, has announced the expansion of its clinical trial ...
Efficacy of Pfizer vaccine against COVID-19: Results from eight European countries
A recent report published in December 2024 by the European Centre for Disease Prevention and Control...
Most Shared
